Flagship V VentureLabs Rx Fund, L.P. is 10% Owner at Sana Biotechnology, Inc. (SANA). They have made 1 open-market trade across 1 company since 2022, most recently 2023-06-07.
CIK 0001724939
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases since 2022, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SANA | SELL | 2023-06-06 | 2023-06-08 | $6.28 | $5.1M | -12.8% | -8.5% | -11.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.